MassMutual Private Wealth & Trust
DYN icon

MassMutual Private Wealth & Trust’s Dyne Therapeutics DYN Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.92K Hold
243
– – ﹤0.01% 1702
2026
Q2 		$5.4K Hold
243
– – ﹤0.01% 1649
2026
Q1 		$4.41K Hold
243
– – ﹤0.01% 1730
2025
Q4 		$4.75K Hold
243
– – ﹤0.01% 1692
2025
Q3 		$3.07K Hold
243
– – ﹤0.01% 1860
2025
Q2 		$2.31K Buy
+243
New +$2.68K ﹤0.01% 1910

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Atlas Venture Life Science Advisors
Atlas Venture Life Science Advisors Cambridge, Massachusetts $631M AUM 38.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

MassMutual Private Wealth & Trust's DYN Position: Q3 2026 in Review

MassMutual Private Wealth & Trust held its Dyne Therapeutics (DYN) position steady in Q3 2026 at 243 shares worth $3.92K. The position accounts for ﹤0.01% of the portfolio, ranked #1702.

MassMutual Private Wealth & Trust first reported a position in DYN in Q2 2025 and has held it in 6 quarters since. The position peaked at $5.4K in Q2 2026. 109 funds tracked by Wall St. Rank hold DYN as of Q3 2026.

  • MassMutual Private Wealth & Trust held 243 shares of Dyne Therapeutics worth $3.92K as of Q3 2026.
  • MassMutual Private Wealth & Trust left its Dyne Therapeutics share count unchanged in Q3 2026.
  • Dyne Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q3 2026, its #1702 holding.
  • MassMutual Private Wealth & Trust first reported a position in Dyne Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • MassMutual Private Wealth & Trust's Dyne Therapeutics position peaked at $5.4K in Q2 2026.
  • 109 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.